Table 2. nAbs during acute HCV infection.
| Neutralization by plasma collected at different times after infection,* %
|
|||
|---|---|---|---|
| Patient | Week | HIV-HCV H77 | HIV-HCV HCJ4 |
| 1 | 2 | – | – |
| 7 | – | – | |
| 12 | – | – | |
| 17 | – | – | |
| 70 | – | – | |
| 112 | – | – | |
| 2 | 4 | – | – |
| 11 | – | – | |
| 23 | – | – | |
| 64 | – | – | |
| 3 | 38 | – | – |
| 81 | – | – | |
| 135 | – | – | |
| 260 | – | – | |
| 395 | – | – | |
| 4 | 6 | – | – |
| 17 | – | – | |
| 59 | – | – | |
| 93 | 91 | – | |
| 5 | 15 | 89 | – |
| 71 | 93 | 50 | |
| 97 | 80 | 50 | |
| 130 | 60 | 54 | |
| 6 | 49 | – | – |
| 80 | – | – | |
| 171 | – | – | |
| 572 | – | – | |
| 7 | 232 | – | – |
| 316 | – | – | |
–, percentage neutralization <50%.
All plasma samples were tested at a dilution of 1/200